In Canada, Oligo Medic, a medical device company that develops biomaterials for regenerative medicine and is known for JointRep for cartilage treatment in body joints, has a new CEO, Jerett A. Creed. Creed’s career started with Johnson and Johnson focusing on angioplasty balloons and metal stents, as CFO of a publicly traded oil and gas company and CEO of Cardigant Medical, but has evolved with his 20 years of experience in the medical technology field. Creed led Oligo Medic’s launch of their JointRep product in Latin America. He has also been involved in 2 public offerings as well as more than $650 million merger and acquisition activities for Oligo Medic.
Latest article
Tums battles heartburn and climate change with new biobased packaging
In Missouri, the multinational behind Tums has partnered with Pretium Packaging and LyondellBasell to create a biobased bottle for the antacid.
At the recent...
Vegan Society certifies interior of Mercedes-Benz GLC
In Germany, Mercedes-Benz’s GLC model has become the first car to have an interior certified by the Vegan Society. Vegan materials were used throughout the...
Wooden Bentley replica finds a home in Boca Raton
In Boca Raton, the Auto Sport Florida group has acquired a wooden replica of the original Bentley Continental GT, with sculpted wood being used...